Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:40 AM
Ignite Modification Date:
2025-12-25 @ 1:40 AM
NCT ID:
NCT05248594
Eligibility Criteria:
Inclusion Criteria: Patients must meet the following criteria for study entry:
* Patients who have been prescribed Emicizumab
* Patients who are 0-36 months of age at the time of starting treatment with Emicizumab
* Diagnosis of congenital mild, moderate or severe hemophilia with or without an inhibitor
Exclusion Criteria:
* Patients with acquired Hemophilia A
* Patients with Hemophilia A and another congenital or acquired bleeding disorder.
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
36 Months
Study:
NCT05248594
Study Brief:
Protocol Section:
NCT05248594